Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-07-29 to 2025-08-19
Current total value of award: $5026.9
Description: 4568938804!OZURDEX 0.7 MG IMPLANTS